Trademarkia Logo

United Kingdom

£
Trademark Search
Myricx

View On IPO.GOV.UK

Application Published

on 28 Feb 2025

Last Applicant/ Owned by

Myricx Pharma Limited

London Innovation Centre, 20 Water Street, Canary Wharf

London, , E14 5GX

Serial Number

UK00004166930 filed on 28th Feb 2025

Correspondent Information

Penningtons Manches Cooper LLP

9400 Garsington Road, Oxford Business Park

Oxford,

OX4 2HN

Myricx

pharmaceutical and biotechnological preparations; pharmaceutical and biotechnological preparations for the diagnosis and treatment of human diseases; Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical and biotechnological preparations; pharmaceutical and biotechnological preparations for the diagnosis and treatment of human diseases; pharmaceutical and biotechnological preparations for the diagnosis and treatment of proliferative human diseases; pharmaceutical and biotechnological preparations for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; antibody drug conjugates (ADCs); antibody drug conjugates (ADCs) for the diagnosis and treatment of human diseases; antibody drug conjugates (ADCs) for the diagnosis and treatment of proliferative human diseases; antibody drug conjugates (ADCs) for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; N-myristoyltransferases (NMT) inhibitors; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of human diseases; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of proliferative human diseases; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging.

Class [42]
Computer & Software Services & Scientific Services

Scientific and biomedical research; scientific and biomedical research in the field of human diseases; scientific and biomedical research in the field of proliferative human diseases; scientific and biomedical research in the field of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; development, testing and commercialisation of pharmaceuticals and biotechnological preparations; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of human diseases; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of proliferative human diseases; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; development, testing and commercialisation of antibody drug conjugates (ADCs) and N-myristoyltransferases (NMT) inhibitors; consultancy, advisory and information services relating to the aforesaid services.

Mark Details

Serial Number

UK00004166930

Mark Type

Word

Kind of mark

Individual